The present invention provides for a fuel compositions are provided comprising a hydrogenation product of a tricyclic sesquiterpene (epi-isozizaene, pentalenene, or -isocomene) and a fuel additive. Methods of making and using the fuel compositions are also disclosed.

A space-bred seawater Spirulina H11 strain. The strain exhibits high growth rate, capacity of simultaneously accumulating high contents of phycocyanin, Spirulina polysaccharides and -carotene, and excellent adaptability to outdoor environment, thus can be used to produce high-quality Spirulina powders, phycocyanin, Spirulina polysaccharides, and -carotene-rich Spirulina oil.

The present invention relates to the production of hydrolyzates from a lignocellulose-containing material, and to fermentation of the hydrolyzates. More specifically, the present invention relates to the detoxification of phenolic inhibitors and toxins formed during the processing of lignocellulose-containing material by enzymatically sulfating the phenolic inhibitors and toxins using aryl sulfotranseferases.

A process is described for producing BTX and alcohols from biomass, by a) catalytic pyrolysis of the biomass in a fluidized-bed reactor producing a gaseous pyrolysis effluent; b) separation of said gaseous pyrolysis effluent into at least one BTX fraction and a gaseous effluent containing at least carbon monoxide and carbon dioxide, c) sending all of the gaseous effluent from separation b) into fermentation producing a liquid fermentation stream containing at least one stream containing at least one oxygenated compound chosen from alcohols, diols, acid alcohols, carboxylic acids, aldehydes, ketones and esters, d) separating the fermentation stream obtained on conclusion of c) into at least the stream containing at least one oxygenated compound, an aqueous fraction, and an unreacted gaseous effluent, e) recycling at least part of unreacted gaseous effluent into the catalytic pyrolysis a).

The disclosure provides biocatalysts that halogenate complex chemical compounds in specific and predictable ways. Also disclosed are halogenated complex organic compounds. The disclosure further provides methods for the halogenation of complex chemical compounds and methods of inhibiting the contraction of smooth muscle in mammals.

A method for producing individual or libraries of tri- to pentadecaketide-derived aromatic compounds of interest by heterologous expression of polyketide synthase and aromatase/cyclase in a recombinant host cell.

Aspects of the invention relate to methods of producing small molecules for industrial application using natural organisms and engineered organisms.

The disclosure provides biocatalysts that halogenate complex chemical compounds in specific and predictable ways. Also disclosed are halogenated complex organic compounds. The disclosure further provides methods for the halogenation of complex chemical compounds and methods of inhibiting the contraction of smooth muscle in mammals.

The present invention generally relates to the field of biotechnology as it applies to the production of aryl sulfates using recombinant host cells. More particularly, the present invention pertains to recombinant host cells comprising (e.g., expressing) a polypeptide having aryl sulfotransferase activity, wherein said recombinant host cells have been modified to have an increased uptake of sulfate compared to identical host cells that does not carry said modification. Further provided are processes for the production of aryl sulfates, such as zosteric acid, employing such recombinant host cells.

Methods for catalyzing CH insertion reactions using heme enzymes are described. The present disclosure provides a method for producing a CH insertion product comprising providing an substrate having an sp.sup.3-hybridized CH bond, a carbene precursor such as a diazo reagent, and a heme enzyme, and admixing the components in a reaction for a time sufficient to produce the CH insertion product. Heme enzyme variants useful for carrying out in vivo and in vitro CH insertion reactions, as well as expression vectors and host cells expressing the heme enzymes, are also described.